Am J Cancer Res

1. 
   Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4 [Retraction].
   Am J Cancer Res. 2025;15:5395.
   

   >> Share

   
   

   
   Ann Oncol

2. CONTIERI R, Mollica V, Shariat SF, Pradere B, et al
   Comment to: ALBAN (GETUG-AFU 37): A phase 3, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guerin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle invasive bladder cancer (NMIBC).
   Ann Oncol. 2026 Jan 13:S0923-7534(26)00012-8. doi: 10.1016/j.annonc.2026.
   

   >> Share

   
   
3. DYRSKJOT L, Birkenkamp-Demtroder K, Nordentoft I, Strandgaard T, et al
   ctDNA-Guided Immunotherapy following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results from the TOMBOLA Trial.
   Ann Oncol. 2026 Jan 14:S0923-7534(26)00011-6. doi: 10.1016/j.annonc.2025.
   

   >> Share

   
   

   
   Ann Surg Oncol

4. HAJIME T, Shiota M, Fukuchi G, Mutaguchi J, et al
   Tumor Laterality Predicts Pelvic Lymph Node Metastasis Patterns in Bladder Cancer.
   Ann Surg Oncol. 2026 Jan 16. doi: 10.1245/s10434-026-19088.
   

   >> Share

   
   

   
   Asia Pac J Oncol Nurs

5. DAI Y, Zhang X, Lin Q, Gu X, et al
   Best evidence summary on gastrointestinal function recovery after radical cystectomy for bladder cancer.
   Asia Pac J Oncol Nurs. 2025;13:100824.
   

   >> Share

   
   

   
   BMC Urol

6. AYDIN ME, Aykac A, Kaya C, Sungur M, et al
   Comparative analysis of EAU, AUA, and NCCN guidelines for the management of non-muscle invasive bladder cancer.
   BMC Urol. 2026 Jan 12. doi: 10.1186/s12894-026-02045.
   

   >> Share

   
   
7. ILKI FY, Bulbul E, Topcu YK, Cinar O, et al
   Comparison of intravesical Bacillus Calmette-Guerin and chemohyperthermia with mitomycin C in with high-risk non-muscle-invasive bladder cancer: a critical assesment focusing on the quality of life and adverse events.
   BMC Urol. 2026 Jan 14. doi: 10.1186/s12894-025-02040.
   

   >> Share

   
   

   
   Cancer Biol Ther

8. ZHU M, Liu Y, Jia Y, Ren L, et al
   Jujuboside A induces bladder cancer cell apoptosis by inhibiting ATP1A2-mediated mitochondrial energy metabolism regulation.
   Cancer Biol Ther. 2026;27:2615418.
   

   >> Share

   
   

   
   Cancer Res Treat

9. PARK I, Lee JL, Yoon S, Shin SJ, et al
   A Multicenter Phase II Study of Modified FOLFIRINOX for First-Line Treatment for Advanced Urachal Cancer (ULTIMA; KCSG GU20-03).
   Cancer Res Treat. 2026;58:284-291.
   

   >> Share

   
   

   
   Chin J Cancer Res

10. ZHANG F, Yang Y, Zhang R, Hu H, et al
    Curcumol overcomes cisplatin resistance and rewires glycolysis-H3K9la-ORC6 axis to trigger ferroptosis in bladder cancer.
    Chin J Cancer Res. 2025;37:1034-1057.
    

    >> Share

    
    

    
    Clin Cancer Res

11. CHEVRIER S, Richard C, Adotevi O, Ayyoub M, et al
    Circulating transcriptome analysis finds gene signatures and immune cell activation and abundance predict response to immunotherapy in bladder cancer.
    Clin Cancer Res. 2026 Jan 13. doi: 10.1158/1078-0432.CCR-25-2306.
    

    >> Share

    
    

    
    Clin Chim Acta

12. FULORIA NK, Narain K, Biswas A, Gnanam P, et al
    Tissue polypeptide antigen as a non-invasive bladder Cancer biomarker.
    Clin Chim Acta. 2026 Jan 13:120843. doi: 10.1016/j.cca.2026.120843.
    

    >> Share

    
    

    
    Clin Nucl Med

13. MAN X, Zhang X, Dong A, He J, et al
    Isolated Vaginal Recurrence of Urothelial Bladder Cancer on FDG PET/CT.
    Clin Nucl Med. 2026 Jan 6. doi: 10.1097/RLU.0000000000006294.
    

    >> Share

    
    

    
    Clin Transl Oncol

14. FERNANDEZ O, Molina A, Anido-Herranz U, Alvarez C, et al
    Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study.
    Clin Transl Oncol. 2026;28:254-264.
    

    >> Share

    
    

    
    Cureus

15. LAERT J, Lupi Manso N, Franca de Santana T, Santos PO, et al
    Pitfalls and Limitations of the Vesical Imaging-Reporting and Data System (VI-RADS): Challenges in the Multiparametric Magnetic Resonance Imaging (mpMRI) Assessment of Bladder Cancer.
    Cureus. 2025;17:e99197.
    

    >> Share

    
    

    
    Curr Urol Rep

16. ARON S, Meagher M, Azari S, Baker B, et al
    Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and Treatment.
    Curr Urol Rep. 2026;27:8.
    

    >> Share

    
    

    
    Cyborg Bionic Syst

17. HUANG H, Ye F, Liu T, Hong J, et al
    Nano-Immunotherapy Synergizing Ferroptosis and STING Activation in Metastatic Bladder Cancer.
    Cyborg Bionic Syst. 2026;7:0458.
    

    >> Share

    
    

    
    Discov Oncol

18. CHEN J, Liu X, Ren R, Yi R, et al
    Single-cell and immune-context integration identifies basement-membrane/metastasis signatures that sharpen bladder-cancer diagnosis and prognosis.
    Discov Oncol. 2026 Jan 14. doi: 10.1007/s12672-026-04440.
    

    >> Share

    
    
19. GE T, Liu F, Cai M, Wu J, et al
    Using transcriptomics and molecular docking to uncover the pharmacological targets and its associated biological mechanisms of paeoniflorigenone in treating bladder cancer.
    Discov Oncol. 2026 Jan 14. doi: 10.1007/s12672-026-04404.
    

    >> Share

    
    

    
    Eur J Pharm Biopharm

20. MARAMI S, Tavakoli MH, Pashaki AS, Nikzad S, et al
    Computational analysis of the impact of urine volume on magnetic nanoparticle hyperthermia in the treatment of non-muscle-invasive bladder cancer.
    Eur J Pharm Biopharm. 2026 Jan 14:114992. doi: 10.1016/j.ejpb.2026.114992.
    

    >> Share

    
    

    
    Eur Urol

21. ROVIELLO G, Vascotto IA, Antonuzzo L
    Re: ctDNA-guided Adjuvant Atezolizumab in Muscle-invasive Bladder Cancer.
    Eur Urol. 2026 Jan 12:S0302-2838(26)00008-4. doi: 10.1016/j.eururo.2026.
    

    >> Share

    
    
22. HERR H
    Re: Oscar Buisan, Pol Servian, Sonia Pedreno-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guerin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol.
    Eur Urol. 2026 Jan 12:S0302-2838(25)04897-3. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    

    
    Eur Urol Oncol

23. MARIAPPAN P, Hart-Brooke J, Sparks R, Lord-McKenzie T, et al
    Reply to Matthias May, Ingmar Wolff, Sabine Brookman-May, and Maximilian Burger's Letter to the Editor re: Paramananthan Mariappan, Jasmin Hart-Brooke, Rebecca Sparks, Tanya Lord-McKenzie. Bladder EpiCheck Triggered Photodynamic Diagnosis Biopsies Det
    Eur Urol Oncol. 2026 Jan 13:S2588-9311(25)00344.
    

    >> Share

    
    

    
    Expert Rev Anticancer Ther

24. SALZANO G, Digiacomo A, Dello Stritto G, Orsini A, et al
    Artificial intelligence in bladder cancer management: a narrative review of diagnostic and surgical advances and current limitations.
    Expert Rev Anticancer Ther. 2026 Jan 16. doi: 10.1080/14737140.2026.2619018.
    

    >> Share

    
    

    
    Gan To Kagaku Ryoho

25. KASUKAWA S, Kametaka H, Makino H, Fukada T, et al
    [A Case of Pelvic Abscess Treated with Transperineal Drainage for Lower Gastrointestinal Perforation in Terminal Cancer].
    Gan To Kagaku Ryoho. 2025;52:1189-1191.
    

    >> Share

    
    
26. HATAKEYAMA T, Maeda T, Ide S
    [A Case of Synchronous Primary Cancers of the Rectum and Bladder].
    Gan To Kagaku Ryoho. 2025;52:1129-1130.
    

    >> Share

    
    

    
    Genes Genomics

27. CAO N, Cheng F
    TSTA3 promotes the malignant progression of bladder cancer by regulating LAMP2 and MAPK signaling pathway-mediated epithelial-mesenchymal transition.
    Genes Genomics. 2026 Jan 14. doi: 10.1007/s13258-025-01724.
    

    >> Share

    
    

    
    Geriatr Gerontol Int

28. SASAKI Y, Izumi K, Fukuta K, Kadoriku F, et al
    Robot-Assisted Radical Cystectomy in the Very Elderly: A Propensity Score-Matched Comparison of Outcomes Between Patients Aged >/= 85 Versus 75-84 Years.
    Geriatr Gerontol Int. 2026;26:e70346.
    

    >> Share

    
    

    
    Hum Pathol

29. KAYRAKLIOGLU N, Zhang L, Cornelia Ding CK, Greenland NY, et al
    Correlation of lymphocytic infiltration and degree of pleomorphism with tumor mutation burden in high-grade urothelial carcinoma.
    Hum Pathol. 2026;167:106005.
    

    >> Share

    
    

    
    IJU Case Rep

30. OKA R, Goto Y, Mikami K, Kato H, et al
    Renal Granuloma Distinct From the Renal Pelvis Following Bacillus Calmette-Guerin Treatment for Bladder Cancer: A Case Report.
    IJU Case Rep. 2026;9:e70141.
    

    >> Share

    
    

    
    Int J Biol Sci

31. DE ALMEIDA MF, Rosa BG, Delechiave D, Annequin LF, et al
    rBCG-LTAK63 Outperforms BCG in Bladder Cancer Immunotherapy: Dendritic and T Cell Coordination Drives Superior Tumor Control in a Mouse Model.
    Int J Biol Sci. 2026;22:713-730.
    

    >> Share

    
    

    
    Int J Cancer

32. NIEDERSUESS-BEKE D, Mayrhofer K, Krauter J, Franke J, et al
    Enfortumab vedotin plus pembrolizumab in treatment-naive metastatic urothelial carcinoma patients: An Austrian real-world analysis.
    Int J Cancer. 2026;158:1654-1665.
    

    >> Share

    
    

    
    Int J Urol

33. HIRATA H
    Editorial Comment on Oligometastatic Prostate and Bladder Cancer: An Integrative Narrative Review.
    Int J Urol. 2026;33:e70343.
    

    >> Share

    
    
34. IWASAWA T, Tsujino T, Tsukahara S, Fukushima H, et al
    Translational Advances in Urothelial Carcinoma: From Bench to Bedside.
    Int J Urol. 2026;33:e70341.
    

    >> Share

    
    

    
    Int Urol Nephrol

35. CHAI Y, Zhou Y, Peng H, Jiang Y, et al
    Comparative efficacy of hyperthermic chemotherapy and BCG instillation in non-muscle invasive bladder cancer: a systematic review and meta-analysis.
    Int Urol Nephrol. 2026 Jan 11. doi: 10.1007/s11255-026-05008.
    

    >> Share

    
    

    
    Integr Biol (Camb)

36. ZHANG Q, Zhang B, Niu J, Sun S, et al
    POSTN+ cancer-associated fibroblasts promote bladder cancer progression via angiogenesis and immune modulation: an analysis based on single-cell Transcriptomics.
    Integr Biol (Camb). 2026;18:zyag001.
    

    >> Share

    
    

    
    Ir J Med Sci

37. KHAN JS, Lonergan PE, McLoughlin LC
    Adherence to Bacille Calmette-Guerin protocol in the management of non-muscle invasive bladder cancer at St James's Hospital.
    Ir J Med Sci. 2026 Jan 17. doi: 10.1007/s11845-025-04260.
    

    >> Share

    
    

    
    J Magn Reson Imaging

38. CHEN L, Jin C, Guo E, Liu F, et al
    The Performance of MR Cytometry Imaging in Differentiating High- and Low-Grade Bladder Cancer.
    J Magn Reson Imaging. 2026 Jan 11. doi: 10.1002/jmri.70232.
    

    >> Share

    
    
39. MUMUNI AN
    Editorial for "The Performance of MR Cytometry Imaging in Differentiating High- and Low-Grade Bladder Cancer".
    J Magn Reson Imaging. 2026 Jan 11. doi: 10.1002/jmri.70238.
    

    >> Share

    
    

    
    J Robot Surg

40. DENIAUD C, Mesnard B, Bobet S, Perrouin-Verbe MA, et al
    Morbi-mortality of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type.
    J Robot Surg. 2026;20:173.
    

    >> Share

    
    

    
    Jpn J Clin Oncol

41. KAWAI T, Miki J, Taoka R, Saito R, et al
    Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan.
    Jpn J Clin Oncol. 2026 Jan 16:hyaf218. doi: 10.1093.
    

    >> Share

    
    

    
    Mikrochim Acta

42. WU X, Zhou Y, Chen J, Zhang H, et al
    A high-throughput photothermal aptasensing platform using MnO(2)@CuS nanoprobes for noninvasive detection of bladder cancer cells in simulated liquid biopsy.
    Mikrochim Acta. 2026;193:88.
    

    >> Share

    
    

    
    Minerva Urol Nephrol

43. SUNGUR U, Bitkin A, Eksi M, Polat H, et al
    Machine learning methods for predicting early recurrence in Ta stage bladder cancer and comparison with conventional statistical methods.
    Minerva Urol Nephrol. 2026 Jan 12. doi: 10.23736/S2724-6051.25.06385.
    

    >> Share

    
    

    
    Nat Rev Urol

44. AL-SATTAR H, Ding H, Okoli O, Okoli S, et al
    A multi-modal approach for decision making in bladder cancer.
    Nat Rev Urol. 2026 Jan 14. doi: 10.1038/s41585-025-01122.
    

    >> Share

    
    

    
    Part Fibre Toxicol

45. CHENG YT, Lu KH, Hong SY, Chen CH, et al
    Particulate matter 2.5 promotes bladder cancer cell migration and invasion through the crosstalk between integrin-mediated MAPK/ERK and Wnt/beta-catenin pathways.
    Part Fibre Toxicol. 2026 Jan 16. doi: 10.1186/s12989-025-00656.
    

    >> Share

    
    

    
    Recent Pat Anticancer Drug Discov

46. ZHANG J, Zheng L, Yu Z, Chen Y, et al
    Single-cell and Bulk RNA-Seq Analyses Reveal TOMM7-mediated Multi-cell Death Mechanisms Driving Muscle-invasive Bladder Cancer Progression.
    Recent Pat Anticancer Drug Discov. 2026.
    

    >> Share

    
    

    
    Rev Esp Enferm Dig

47. FERNANDEZ RODRIGUEZ P, Castillo Gazquez L, Tomas Alvarez S, Casals Seoane F, et al
    Abdominal BCGitis with hepatosplenic and lymphatic involvement following intravesical therapy: a rare complication.
    Rev Esp Enferm Dig. 2025;117:797-799.
    

    >> Share

    
    

    
    Rev Med Suisse

48. REYNARD M, Grobet-Jeandin E, Windisch O, Sebe P, et al
    [Urology. Quality of life and safety : the new promises].
    Rev Med Suisse. 2026;22:79-82.
    

    >> Share

    
    

    
    Sci Rep

49. INUI S, Ito S, Ueda T, Shiraishi T, et al
    Efficacy and safety of cryoablation procedures using mouse models of bladder cancer.
    Sci Rep. 2026 Jan 13. doi: 10.1038/s41598-026-35571.
    

    >> Share

    
    

    
    Stem Cells

50. CHENG LH, Hsu CW, Yang PM, Liao TY, et al
    Chemotherapy resistance of urinary bladder cancer mediated by a Notch and Wnt co-regulatory module of stemness.
    Stem Cells. 2026 Jan 10:sxag002. doi: 10.1093.
    

    >> Share

    
    

    
    Trials

51. SYNESI G, Lewis R, Kilburn L, Bliss J, et al
    Reviewing inclusivity of the UK bladder and head and neck oncology trial portfolio through eligibility criteria: a scoping review.
    Trials. 2026;27:19.
    

    >> Share

    
    

    
    Urol Oncol

52. SQUIRES P, Coutinho F, Tepsick JG, Rogiers A, et al
    Real-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice.
    Urol Oncol. 2026;44:110982.
    

    >> Share

    
    
53. DADABHOY A, Doshi C, Zahir M, Ladi-Seyedian S, et al
    Alopecia following single-dose postoperative intravesical gemcitabine in nonmuscle-invasive bladder cancer: A multi-institutional case series.
    Urol Oncol. 2026;44:110984.
    

    >> Share

    
    

    
    World J Surg Oncol

54. ZHOU H, Peng S, Ling Z, Cai J, et al
    Multi-omics analysis identifies BUB1B as a cell cycle-related driver of bladder cancer progression.
    World J Surg Oncol. 2026 Jan 12. doi: 10.1186/s12957-025-04175.
    

    >> Share

    
    
55. YANG J, Li X, Xie H, Guo J, et al
    From mechanisms to therapy: the role of tertiary lymphoid structures in bladder cancer.
    World J Surg Oncol. 2026 Jan 17. doi: 10.1186/s12957-026-04196.
    

    >> Share

    
    

    
    World J Urol

56. SCILIPOTI P, Zaurito P, Longoni M, Tremolada G, et al
    Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study.
    World J Urol. 2026;44:82.
    

    >> Share

    
    
57. DENIAUD C, Mesnard B, Bobet S, Perrouin-Verbe MA, et al
    Oncologic outcomes of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type.
    World J Urol. 2026;44:93.
    

    >> Share

    
    
58. REGNIER S, Gabriel PE, Ouzaid I, Moschini M, et al
    Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer.
    World J Urol. 2026;44:84.
    

    >> Share

    
    
59. MJAESS G, Quackels T, Fantoni JC, Tricard T, et al
    Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004).
    World J Urol. 2026;44:90.
    

    >> Share

    
    
60. PEREZ-LONDONO A, Kaul S, Fleishman A, Korets R, et al
    Repeat transurethral resection and contemporary oncologic outcomes among patients with non-muscle invasive urothelial carcinoma of the bladder.
    World J Urol. 2026;44:91.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share